ERBB2 and neoplasm: In addition, a higher proportion of patients in the HER2-0 group had increased HER2 IHC score after NACT, suggesting that the tumors of these patients were more likely to express HER2 gene or protein after chemotherapy, which might accelerate tumor recurrence and metastasis.